HRT Financial’s iShares Biotechnology ETF IBB Stock Holding History

HRT Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,228	Closed	-$3.75M	–	4207
2025 Q4	$3.75M	Buy	+22,228	New	+$3.61M	0.01%	922
2025 Q3	–	Sell	-10,087	Closed	-$1.28M	–	3211
2025 Q2	$1.28M	Buy	+10,087	New	+$1.24M	0.01%	1138
2024 Q3	–	Sell	-77,664	Closed	-$10.7M	–	2738
2024 Q2	$10.7M	Buy	77,664 +31,076	+67%	+$4.15M	0.06%	236
2024 Q1	$6.39M	Buy	+46,588	New	+$6.36M	0.04%	206
2023 Q4	–	Sell	-31,590	Closed	-$3.86M	–	2657
2023 Q3	$3.86M	Buy	+31,590	New	+$4.02M	0.04%	378
2023 Q2	–	Sell	-40,190	Closed	-$5.19M	–	2816
2023 Q1	$5.19M	Sell	40,190 -17,557	-30%	-$2.3M	0.06%	254
2022 Q4	$7.58M	Sell	57,747 -55,458	-49%	-$7.17M	0.11%	173
2022 Q3	$13.2M	Sell	113,205 -58,467	-34%	-$7.26M	0.14%	106
2022 Q2	$20.2M	Buy	171,672 +71,525	+71%	+$8.49M	0.22%	67
2022 Q1	$13M	Buy	100,147 +42,185	+73%	+$5.5M	0.09%	117
2021 Q4	$8.85M	Buy	57,962 +21,613	+59%	+$3.35M	0.05%	180
2021 Q3	$5.88M	Sell	36,349 -11,848	-25%	-$1.99M	0.04%	278
2021 Q2	$7.89M	Sell	48,197 -22,016	-31%	-$3.39M	0.07%	215
2021 Q1	$10.6M	Buy	70,213 +22,172	+46%	+$3.52M	0.11%	123
2020 Q4	$7.28M	Sell	48,041 -66,618	-58%	-$9.52M	0.15%	111
2020 Q3	$15.5M	Buy	114,659 +74,306	+184%	+$10.1M	0.45%	41
2020 Q2	$5.51M	Buy	+40,353	New	+$5.14M	0.17%	110
2020 Q1	–	Sell	-41,193	Closed	-$4.96M	–	1022
2019 Q4	$4.96M	Sell	41,193 -40,295	-49%	-$4.5M	0.21%	78
2019 Q3	$8.11M	Buy	81,488 +76,521	+1,541%	+$8.01M	0.38%	38
2019 Q2	$541K	Sell	4,967 -2,684	-35%	-$285K	0.03%	395
2019 Q1	$855K	Sell	7,651 -1,479	-16%	-$162K	0.13%	107
2018 Q4	$880K	Sell	9,130 -8,928	-49%	-$948K	0.13%	132
2018 Q3	$2.2M	Buy	+18,058	New	+$2.13M	0.34%	61
2018 Q2	–	Sell	-3,947	Closed	-$421K	–	315
2018 Q1	$421K	Buy	+3,947	New	+$438K	0.2%	100
2017 Q4	–	Sell	-7,452	Closed	-$828K	–	134
2017 Q3	$828K	Sell	7,452 -1,563	-17%	-$167K	1.03%	12
2017 Q2	$931K	Sell	9,015 -25,035	-74%	-$2.47M	1.47%	7
2017 Q1	$3.33M	Buy	34,050 +10,278	+43%	+$984K	3.11%	4
2016 Q4	$2.1M	Sell	23,772 -119,847	-83%	-$10.9M	2.68%	6
2016 Q3	$13.9M	Sell	143,619 -95,868	-40%	-$9.12M	12.2%	2
2016 Q2	$20.5M	Buy	239,487 +214,944	+876%	+$19.3M	12.48%	2
2016 Q1	$2.13M	Sell	24,543 -6,165	-20%	-$551K	2.23%	10
2015 Q4	$3.46M	Buy	+30,708	New	+$3.33M	4.2%	5
2015 Q3	–	Sell	-58,776	Closed	-$7.23M	–	116
2015 Q2	$7.23M	Buy	58,776 +43,023	+273%	+$5.15M	3.4%	3
2015 Q1	$1.8M	Hold	15,753	–	–	2.31%	8
2014 Q4	$1.59M	Buy	+15,753	New	+$1.53M	2.24%	7

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's IBB Position: Q1 2026 in Review

HRT Financial sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 22,228 shares — an estimated $3.75M sold.

HRT Financial first reported a position in IBB in Q4 2014 and held it in 35 quarters. The position peaked at $20.5M in Q2 2016. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

HRT Financial reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 22,228 iShares Biotechnology ETF shares in Q1 2026, an estimated $3.75M.
HRT Financial first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 35 quarters.
HRT Financial's iShares Biotechnology ETF position peaked at $20.5M in Q2 2016.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.